FRNM insider trading
NasdaqCM HealthcareFreenome, Inc.: insider trade history from SEC Form 4 filings.
About Freenome, Inc.
Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops SimpleScreen CRC, a blood-based test, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.
Company website: www.freenome.com
FRNM insider activity at a glance
FilingIQ tracks 15 insider transactions for FRNM in filings since Jul 22, 2026. The most recent transaction is dated Sep 2, 2026.
Across the full history, 0 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest FRNM Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for FRNM?
- FilingIQ tracks 15 Form 4 insider transactions for FRNM (Freenome, Inc.), covering filings from Jul 22, 2026 onwards. 1 of those are dated within the last 90 days.
- Are FRNM insiders net buyers or net sellers?
- Across the full Form 4 history for FRNM, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does FRNM insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is FRNM in?
- Freenome, Inc. (FRNM) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $1.74B.
Methodology & sources
Every FRNM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.